The effect of hormone therapy on local and systemic immune parameters in prostate cancer patients undergoing prostatectomy

Trial Profile

The effect of hormone therapy on local and systemic immune parameters in prostate cancer patients undergoing prostatectomy

Not stated
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 01 Dec 2006

At a glance

  • Drugs Bicalutamide (Primary) ; Gonadotropin releasing hormone stimulants
  • Indications Prostate cancer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top